Antithymocyte immunoglobulin (rabbit) is a type of medication used to treat certain autoimmune diseases and conditions. It is also known as ATG or ATG Rabbit. It is a type of immunoglobulin (or antibody) made from rabbit antibodies that are designed to target the body's own immune system. It works by suppressing the activity of the body's abnormal immune cells, which can help reduce symptoms of autoimmune diseases and conditions. ATG Rabbit is usually given as an injection, but can also be given intravenously (through a vein). Common conditions that are treated with ATG Rabbit include aplastic anemia, acute and chronic graft-versus-host-disease, and certain types of leukemia.
Antithymocyte immunoglobulin (rabbit), also known as ATGAM (rabbit), is a medication previously used to suppress the immune system in certain medical conditions. However, similar to Antilymphocyte immunoglobulin (horse) discussed earlier, its use has significantly declined due to the availability of safer and more effective immunosuppressive medications, and it is no longer widely recommended. Here's a breakdown of its characteristics:
Function:
- ATGAM (rabbit) is a heterologous antibody preparation. This means it contains antibodies derived from the blood plasma of rabbits that have been immunized with human thymocytes. Thymocytes are immature T lymphocytes (white blood cells) that develop in the thymus gland.
- These antibodies specifically target human T lymphocytes, similar to ALG (horse). By binding to T lymphocytes, ATGAM (rabbit) suppresses their function, ultimately weakening the immune system's overall activity.
Previous Uses:
- ATGAM (rabbit) was previously used to treat various conditions requiring immunosuppression, including:
- Organ transplant rejection: To prevent the body from rejecting a transplanted organ.
- Aplastic anemia: A condition where the bone marrow doesn't produce enough red blood cells, white blood cells, and platelets.
- GvHD (graft-versus-host disease): A serious complication that can occur after a bone marrow transplant, where the transplanted stem cells attack the recipient's body.
Reasons for Decline in Use:
- Safety concerns: Similar to ALG (horse), ATGAM (rabbit) can cause serious side effects like:
- Serum sickness: A severe allergic reaction characterized by fever, rash, joint pain, and other symptoms.
- Increased risk of infections: Due to the weakened immune system.
- Anaphylaxis: A life-threatening allergic reaction.
- Availability of safer alternatives: Newer immunosuppressive medications, such as cyclosporine and tacrolimus, offer similar benefits with fewer side effects.
Current Status:
- Due to the safety concerns and availability of safer alternatives, ATGAM (rabbit) is no longer widely recommended.
- Its use is extremely rare and would only be considered as a last resort in exceptional cases where other options have been exhausted and under the careful supervision of a specialist.
Important Note:
- This information is for educational purposes only and should not be interpreted as medical advice.
- If you have any questions or concerns about your health or about ATGAM (rabbit), always consult with a healthcare professional.